Shiatsu Adjuvant Therapy And Placebo For Schizophrenia
1 other identifier
interventional
150
1 country
1
Brief Summary
In the current study we will study the effect of adding acupressure (shiatsu) to conventional therapy in treating individuals with schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable schizophrenia
Started Jan 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2008
CompletedFirst Posted
Study publicly available on registry
November 11, 2008
CompletedStudy Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJanuary 13, 2009
January 1, 2009
2.9 years
November 10, 2008
January 12, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brief Psychiatric Rating Scale (BPRS)
16 weeks
Study Arms (3)
Acupressure
EXPERIMENTALAcupressure adjuvant therapy
Placebo acupressure
PLACEBO COMPARATORSham acupressure adjuvant therapy
No treatment
NO INTERVENTIONWait list group (no treatment)
Interventions
Acupressure provided in 40-minute sessions, twice a week for 4 weeks. For placebo acupressure, different meridian points will be used.
Eligibility Criteria
You may qualify if:
- DSM-IV diagnosis of schizophrenia or schizoaffective disorder
- Ages 18 and over
- Clinical status stable, as reflected by changes in Brief Psychiatric Rating Scale (BPRS) (Overall \& Gorham, 1961) of less than 20% during a one month period prior to randomization, and at least one month of drug treatment without change of anti-psychotic drug or dosage.
- Ability to cooperate with 40-minute sessions
You may not qualify if:
- Unstable general medical conditions
- Active bone fracture or other orthopedic problem
- Skin condition that renders treatment unsafe or painful
- Active infection in skin or soft tissues, such as cellulitis
- Solid tissue malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Herzog Hospitallead
Study Sites (1)
Herzog Hospital, Department of Psychiatry
Jerusalem, 91351, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pesach Lichtenberg, M.D.
Herzog Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 10, 2008
First Posted
November 11, 2008
Study Start
January 1, 2009
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
January 13, 2009
Record last verified: 2009-01